Research progress of small molecule protein kinase inhibitors (SMKIs) in the treatment of colorectal cancer: mechanism, application, and future prospects. [PDF]
Liu L +7 more
europepmc +1 more source
Mitochondria‐targeted nanotherapies emerge as a promising strategy for combating aging‐associated neurodegenerative disorders (NDs) by restoring mitochondrial function, reducing oxidative stress, and improving neuronal survival. Recent advances in nanotechnology, therapeutic delivery, and translational research are highlighted, providing insights into ...
Dnyandev G. Gadhave +8 more
wiley +1 more source
Host Protein Kinase C⍺: The novel Mitogen Activated Protein Kinase (MAPK) specific scaffold regulating nuclear export of influenza virus ribonucleoprotein complexes. [PDF]
Das Jana I +4 more
europepmc +1 more source
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari +10 more
wiley +1 more source
Conventional therapies suffer from poor blood–brain barrier (BBB) penetration and disordered ion/reactive oxygen species (ROS) homeostasis, hindering precise neurological treatment. Electrochemical strategies achieve accurate spatiotemporal regulation of neural homeostasis.
Xiaokang Hu +5 more
wiley +1 more source
[Retracted] Homeobox B9 facilitates hypertrophic scar formation via activating the mitogen‑activated protein kinase signaling pathway. [PDF]
Xie Q +6 more
europepmc +1 more source
An inhibitor of GCN2 and the integrated stress response directly targets ZAK protein kinase to limit cytotoxicity. [PDF]
Misra J +5 more
europepmc +1 more source
[Expression of Concern] Promoter methylation of death‑associated protein kinase and its role in irradiation response in cervical cancer. [PDF]
Leung RC +6 more
europepmc +1 more source
Cerebellar hypoplasia caused by calcium/calmodulin-dependent serine protein kinase deficiency. [PDF]
Tabuchi K +3 more
europepmc +1 more source
Correction for You et al., p53-dependent inhibition of FKHRL1 in response to DNA damage through protein kinase SGK1. [PDF]
europepmc +1 more source

